Clinical Study

Breakthrough in Women's Health

Format: PDF file | Document type: Clinical Study | Promoted Content

This content is provided by Biosearch Life, and any views and opinions expressed do not necessarily reflect those of

Breakthrough in Women's Health

A new study ​performed on women with polycystic ovary syndrome (PCOS) and fertility problems has been published in Gynecological Endocrinology​. Results of this comparative study showed a striking increase in the pregnancy rate of 65.5%​ after treatment with 1,100 mg MI+300 mg DCI in contrast to 25.9% in women receiving 40:1 ratio. Based on these results, Biosearch Life has launched a new product with a combination of MI and DCI (Caronositol®​) at the 3.6:1 ratio.​ The objective of this new product is to improve the success of fertility treatments in women affected by PCOS.

Latest content from Biosearch Life

Related resources from Biosearch Life

Supplier info centre